![Lei Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lei Yang
Voorzitter bij Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Actieve functies van Lei Yang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Hubei Grand Life Science & Technology Co., Ltd
![]() Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Directeur/Bestuurslid | - | - |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Voorzitter | - | - |
Loopbaan van Lei Yang
Statistieken
Internationaal
China | 3 |
Operationeel
Director/Board Member | 1 |
Chairman | 1 |
Sectoraal
Health Technology | 2 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Hubei Grand Life Science & Technology Co., Ltd
![]() Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Health Technology |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |